BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lundberg Båve A, Bergquist A, Bottai M, Warnqvist A, von Seth E, Nordenvall C. Increased risk of cancer in patients with primary sclerosing cholangitis. Hepatol Int 2021. [PMID: 34357546 DOI: 10.1007/s12072-021-10214-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Gao X, He Z, Jia H, Chen M, Wang X, Hong L, Cui Y, Wan J. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis. Liver Int 2022. [PMID: 35689520 DOI: 10.1111/liv.15339] [Reference Citation Analysis]
2 Trivedi PJ, Bowlus CL, Yimam KK, Razavi H, Estes C. Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00919-8. [PMID: 34474162 DOI: 10.1016/j.cgh.2021.08.039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]